MAR 28, 2019 8:18 PM PDT

Cancer Patients Prefer Higher Potency Medical Marijuana, Study Finds

WRITTEN BY: Amy Loriaux

A recent study published in the Journal of Palliative Medicine by Dr. Arum Kim, MD, and colleagues, from the New York University School of Medicine suggests that cancer patients differ from non-cancer patients in how they use marijuana. Apparently, people with cancer prefer a higher amount of THC, while patients suffering from epilepsy or multiple sclerosis would rather have more cannabidiol (CBD) in their formulations.

https://assets.labroots.com/_public/_files/system/ck/trending/CBD%20oil%20unsplash_9631d4c6248e3231d666692738ecd81a.jpg

Photo source: UnSplash.com

The higher amount of THC is preferred for its effects on cancer symptoms and the side effects of cancer treatment, including chronic pain, weight loss, and nausea. In contrast, strains or formulations with greater amounts of CBD were more popular among non-cancer patients, including those with epilepsy and multiple sclerosis. Strains higher in CBD have been shown to reduce seizures and inflammation.

Dr. Kim and her colleagues wanted a clearer picture of the preferences of patients with or without cancer towards different types of medicinal marijuana formulations. They relied on data taken from a medical cannabis dispensary in New York State. They then analyzed demographic information, conditions, symptoms, and the marijuana product used.

There were a total of 11,590 individuals in the study. Nineteen hundred and ninety had cancer and used at least one cannabis product. Patients with cancer using cannabis were older and more likely to be female. The most common qualifying symptom for both cancer and non-cancer patients was severe or chronic pain. Cancer patients were more likely to use the sublingual tincture form of cannabis, while noncancer patients were more likely to vape. Over time, both types of patients increased their daily dose. This could be to tolerance, which can occur quickly with chronic use.

https://assets.labroots.com/_public/_files/system/ck/trending/leaves-unsplash_dc450c257bf579251d6377d05e81a767.jpg

Photo source: UnSplash.com

"Although there is growing patient interest in medical cannabis, there is a scarcity of solid evidence about the benefits, risks, and patterns of use of marijuana products in various disease settings," says Dr. Kim, "Such information is important for delivering the best care." According to an article appearing in ScienceDaily, another investigator on the study, Dr. Benjamin Han, MD, MPH, explained the clinical relevance of their study. "In the absence of strong clinical research data for medical marijuana, identifying patterns of use offers some sense of how to guide patients who come in with questions for using medical marijuana, and what may or may not help them."

Now that the researchers have an idea for the patterns of use in different patient populations they now intend to investigate how medical marijuana affects patient response to therapy at different stages of their disease, as well as the risks and side effects of treatment. They also plan to investigate other cannabinoids besides THC and CBD in medical marijuana in future studies to get an idea for what may or may not be best formulations to prescribe patients depending on their disease.

Sources: Journal of Palliative Medicine, Journal of Neurology, Bioorganic and Medicinal Chemistry, Neuroscience and Biobehavioral Reviews, ScienceDaily

About the Author
  • I currently work at a small CRO involved in clinical trial management.
You May Also Like
NOV 23, 2020
Health & Medicine
Federal Report Shows Teen Marijuana Treatment Admissions Have Been Falling
NOV 23, 2020
Federal Report Shows Teen Marijuana Treatment Admissions Have Been Falling
Concerns that the legalization of recreational marijuana might cause an upswing in young people misusing the drug have b ...
DEC 18, 2020
Health & Medicine
Not Just THC and CBD: Study Investigates Potential of Minor Cannabinoids
DEC 18, 2020
Not Just THC and CBD: Study Investigates Potential of Minor Cannabinoids
Cannabinoids are the natural compounds in the cannabis plant that interact with the body's endocannabinoid system.&n ...
DEC 31, 2020
Plants & Animals
Could CBD be a food preservative?
DEC 31, 2020
Could CBD be a food preservative?
CBD (cannbidiol) oil from has many claims made for it — and now lengthening the shelf life of fresh fruit could fe ...
JAN 09, 2021
Cannabis Sciences
Cannabis Use Does not Increase Risk of Heart Disease
JAN 09, 2021
Cannabis Use Does not Increase Risk of Heart Disease
Previous studies on how cannabis affects cardiovascular health have delivered mixed results. Now, from a study of over 5 ...
MAR 17, 2021
Health & Medicine
CBD Inhibits Brain Changes that Initiate  Alzheimer's: Animal Study
MAR 17, 2021
CBD Inhibits Brain Changes that Initiate Alzheimer's: Animal Study
Cannabidiol, or CBD — the main non-psychoactive ingredient in cannabis — may inhibit some triggers for Alzhe ...
APR 08, 2021
Health & Medicine
Patented Mix of Terpenes and CBD Has Potential to Help COVID
APR 08, 2021
Patented Mix of Terpenes and CBD Has Potential to Help COVID
Israeli-based technology firm Eybna, who specialize in isolating and testing components from the cannabis plant, say tha ...
Loading Comments...